Product NDC: | 55390-345 |
Proprietary Name: | Etomidate |
Non Proprietary Name: | Etomidate |
Active Ingredient(s): | 2 mg/mL & nbsp; Etomidate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-345 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074593 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080331 |
Package NDC: | 55390-345-10 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 BOX (55390-345-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55390-345-10 |
Proprietary Name | Etomidate |
Package Description | 10 VIAL, SINGLE-DOSE in 1 BOX (55390-345-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55390-345 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Etomidate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080331 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | ETOMIDATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |